文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

346,364+ SCI 论文 与阿拉丁产品引用相关
2,295,288.15 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

热门产品

视图 列表 网格

2 项

设置提升方向
秦烯
Geochemistry · 2024 · IF 2.6

Study on flotation recovery of typical carbon-bearing lead-zinc sulphide ore in Guizhou with pre-decarbonization

Guanghui Li,Zheyi Zhang,Qian Wei,Fen Jiao,Congren Yang,Wei Li,Wenqing Qin

In this study, a new process of pre-flotation decarbonization‑lead flotation‑zinc flotation was proposed to recover valuable metals from a lead‑zinc ore in Guizhou by beneficiation and to determine a reasonable and economic beneficiation process. The results of the study demonstrate that the novel process aids in the flotation of lead and zinc ores in two ways: (1) pre-decarbonization using MIBC (methyl isobutyl carbinol) and kerosene synergistically achieved the lowest loss of lead recovery of 1.94 % and zinc recovery of 1.14 % in the decarbonized product. (2) the successful separation and retrieval of lead and zinc metals were accomplished via a preferential flotation technique, using several combinations of reagents. This procedure yielded a lead recovery rate of 87.64 % and a zinc recovery rate of 94.09 %.

研究领域: 矿物加工工程 · 冶金工程
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
NEUROPHARMACOLOGY · 2025 · IF 4.6

Kinsenoside attenuates ER stress and inhibits inflammatory responses through IL-10/STAT/SOCS3 pathway in chronic pain relief

Wei Wang,Yingzhuo Ding,Chunxia Yu,Qingqing Chi,Xia Fu,Mengjiao Deng,Dongxia Duan,Jinbao Wei,Ronghua Ding,Yufei Xi,Qin Li,Le Ma

Neuro-inflammation contributes to neuropathic pain by sensitizing ionic channels. Kinsenoside, a traditional Chinese medicine, has recognized anti-inflammatory properties. However, it remains unclear whether kinsenoside can be used for pain therapy. Network pharmacology analysis revealed that 57 % of its targets are associated with pain, including inflammation and synaptic transmission. The analgesic effects of kinsenoside were confirmed in SNL and formalin rat models, with ED50 values of 47.99 μg and 36.80 μg, respectively. Transcriptome and WGCNA analyses indicated the involvement of cytokine release, anti-inflammatory activity, and synapse enrichment in the blue module. Furthermore, we confirmed that kinsenoside's efficacy was mainly mediated by IL-10 induction, phosphorylation of STAT3, and SOCS3 expression. Pretreatment with kinsenoside significantly inhibited the release of TNF-α, IL-1β, and IL-6. Kinsenoside also attenuated ER stress in both microglia and neural cells. Molecular docking analysis demonstrated significantly high binding energies of IL-10, STAT3, and SOCS3 with MHC. Additionally, whole-cell recordings revealed that bath application of kinsenoside reduced the frequency and amplitude of spinal glutamatergic transmission in a dose-dependent manner. In summary, pharmacological prediction and biological validation collectively indicate that kinsenoside significantly exerts significant analgesic effects by attenuating ER stress and inhibiting inflammatory responses via the IL-10/p-STAT3/SOCS3 axis, precisely regulating spinal glutamatergic transmission for pain relief.

研究领域: 药理学 · 神经科学 · 分子生物学
✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。